Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Effects of 2-chloroadenosine on cortical epileptic afterdischarges in immature rats

M. Pometlová, H. Kubová, P. Mares,

. 2010 ; 62 (1) : 62-7.

Language English Country Poland

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NR9184 MZ0 CEP Register

Adenosine may represent an endogenous anticonvulsant in the brain. This study focused on the possible anticonvulsant action of an adenosine agonist, 2-chloroadenosine, against cortical epileptic afterdischarges (ADs) in immature rats. Three age groups of rat pups with implanted electrodes were studied: 12-, 18- and 25-days-old. The compound, 2-chloroadenosine, was injected after the first successful stimulation at doses of 1, 4 or 10 mg/kg intraperitoneally, and stimulation at the same intensity was repeated three more times. Movements directly elicited by stimulation, as well as clonic seizures accompanying electroencephalography (EEG) ADs, were markedly suppressed in only the 18-day-old animals. The effects in the 12- and especially the 25-day-old rats were moderate. The duration of the ADs decreased in all three age groups with 2-chloroadenosine treatment, and the shortest AD duration was seen in the treated, 12-day-old rats. The AD suppression also lasted longer in this age group than it did in the older animals. After a brief suppression of the second AD, the treated, 25-day-old group exhibited a significant AD rebound during the third and fourth stimulations. Taken together, our data show that 2-chloroadenosine exhibits an anticonvulsant effect that is dose- and age-dependent.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025826
003      
CZ-PrNML
005      
20140717113626.0
007      
ta
008      
120817s2010 pl f 000 0#eng||
009      
AR
024    7_
$a 10.1016/s1734-1140(10)70243-7 $2 doi
035    __
$a (PubMed)20360616
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Pometlová, Marie $u Charles University, Third Medical School, Department of Normal, Pathological and Clinical Physiology, Ke Karlovu 4, CZ-12000 Prague 2, Czech Republic.
245    10
$a Effects of 2-chloroadenosine on cortical epileptic afterdischarges in immature rats / $c M. Pometlová, H. Kubová, P. Mares,
520    9_
$a Adenosine may represent an endogenous anticonvulsant in the brain. This study focused on the possible anticonvulsant action of an adenosine agonist, 2-chloroadenosine, against cortical epileptic afterdischarges (ADs) in immature rats. Three age groups of rat pups with implanted electrodes were studied: 12-, 18- and 25-days-old. The compound, 2-chloroadenosine, was injected after the first successful stimulation at doses of 1, 4 or 10 mg/kg intraperitoneally, and stimulation at the same intensity was repeated three more times. Movements directly elicited by stimulation, as well as clonic seizures accompanying electroencephalography (EEG) ADs, were markedly suppressed in only the 18-day-old animals. The effects in the 12- and especially the 25-day-old rats were moderate. The duration of the ADs decreased in all three age groups with 2-chloroadenosine treatment, and the shortest AD duration was seen in the treated, 12-day-old rats. The AD suppression also lasted longer in this age group than it did in the older animals. After a brief suppression of the second AD, the treated, 25-day-old group exhibited a significant AD rebound during the third and fourth stimulations. Taken together, our data show that 2-chloroadenosine exhibits an anticonvulsant effect that is dose- and age-dependent.
650    _2
$a 2-chloradenosin $x aplikace a dávkování $x farmakologie $7 D015762
650    _2
$a stárnutí $x fyziologie $7 D000375
650    _2
$a zvířata $7 D000818
650    _2
$a antikonvulziva $7 D000927
650    _2
$a mozková kůra $x účinky léků $x patofyziologie $7 D002540
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a implantované elektrody $7 D004567
650    _2
$a elektroencefalografie $x účinky léků $7 D004569
650    _2
$a epilepsie $x farmakoterapie $x patofyziologie $7 D004827
650    _2
$a epilepsie tonicko-klonická $x farmakoterapie $x patofyziologie $7 D004830
650    _2
$a injekce intraperitoneální $7 D007274
650    _2
$a pohybová aktivita $x účinky léků $7 D009043
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kubová, Hana
700    1_
$a Mares, Pavel
773    0_
$w MED00165879 $t Pharmacological reports : PR $x 1734-1140 $g Roč. 62, č. 1 (2010), s. 62-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20360616 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20140717113927 $b ABA008
999    __
$a ok $b bmc $g 947868 $s 783172
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 62 $c 1 $d 62-7 $i 1734-1140 $m Pharmacol. Reports $n Pharmacol. Rep. $x MED00165879
GRA    __
$a NR9184 $p MZ0
LZP    __
$a Pubmed-20120817/10/03

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...